Managing Whistlelbowers
Compliance Tip of the Day: Using AI to Embed Your Compliance Program
Culture Crafters: Building a Culture of Accountability in the Face of Disasters
Compliance Tip of the Day: Trust and Verify
Compliance Tip of the Day: AI Assistant for Compliance
Compliance Tip of the Day: Costs and Benefits of AI
(Podcast) The Briefing: Who Owns What – Understanding Copyright in Collaborative Projects
Fox on Podcasting: Mastering Content Creation and Personal Branding with Dave Polykoff
Compliance Tip of the Day: How a CFO Views Compliance and Risk
Compliance Tip of the Day: Co-Thinking with AI
Nonprofit Basics: Grant Agreements—Matching Grants, IP, Recoverable Grants & More
Compliance Tip of the Day - Extending Compliance Value Across Your Organization
AI Today in 5: August 12, 2025, The Creating Billionaires Episode
Compliance Tip of the Day: Design - Centric Internal Controls
Compliance Tip of the Day - The ROI of Compliance
Adventures in Compliance: The Novels - The Valley of Fear, Sherlock Holmes’ Investigative Techniques for Today’s Challenges
8 Key Takeaways | Strategies to Drive Influence With and Without Authority
Moving Beyond the Usual Helpline Data
Nonprofit Basics: Grant Agreement Best Practices
From Forest to Fortune: Navigating Workplace Ethics With Robin Hood — Hiring to Firing Podcast
In the latest episode of Health Law Diagnosed , Of Counsel Bridgette Keller hosts a discussion of best practices for interacting and communicating with the FDA....more
In the latest episode of Health Law Diagnosed , Of Counsel Bridgette Keller hosts a discussion of best practices for interacting and communicating with the FDA. Hear from Joanne Hawana and Ben Zegarelli, FDA specialists...more
AGG partner and Life Science team member, Allison Raley, will present a complimentary webinar examining how life sciences companies can overcome challenges in the face of U.S. tariffs. As international trade tensions persist...more
Recorded at NC Life Sciences Organization’s Annual Meeting, Heather and Matthew welcome back a favorite friend of the podcast, Laura Gunter, President of NCLifeSci. We discuss the highlights of the 2024 Annual Meeting such as...more
Hosted by the American Conference Institute, the 19th Annual FCPA & Anti-Corruption Conference for the Life Sciences Industry returns for another exciting year with carefully researched programming based on critical findings...more
FDA’s January 3, 2024, Federal Register notice soliciting comments on the agency’s plan to implement best practices for guidance development got me thinking. What do the data show regarding FDA’s performance in moving...more
Hosted by American Conference Institute, the 28th Annual Conference on Drug & Medical Device Litigation returns for another exciting year with curated programming and networking opportunities with 400+ industry...more
Hosted by American Conference Institute, the 18th Annual Conference on the FCPA & Anti-Corruption for the Life Sciences Industry returns for another exciting year with curated programming that shines a global spotlight on...more
ACI is excited to welcome you back in-person to the 14th Advanced Forum on FCPA & Anti-Corruption for the Life Sciences Industry, taking place on July 21–22, 2022 in Boston! Legal and compliance professionals from...more
It’s not easy getting a drug or device to market. From concept to launch, it takes years of work and the involvement of countless professionals from the engineering, medicine and regulatory disciplines. If the product becomes...more
The firm is pleased to present the latest edition of The Life Sciences Report. This issue features a sampling of recent COVID-19-related client activity in which the firm has been involved, an article on life sciences venture...more
Join us as we celebrate the 25th Anniversary of ACI’s Annual Flagship Conference on Drug & Medical Device Litigation! ACI’s Drug and Medical Device Litigation has united the greatest minds of the pharmaceutical and medical...more
China is cautiously recovering from the peak of the COVID-19 outbreak and is moving into a new period of investor-friendly policies aimed at restarting China’s economic engine....more
U.S. and international health authorities continue to respond to the outbreak of the novel coronavirus (COVID-19). While originally detected in Wuhan City, Hubei Province, China, as of the date of this alert the virus has now...more
Clinical trials have become increasingly important for pharmaceutical companies and medical device manufacturers, which are focused on collecting as much data as possible on products and devices and their adverse effects. All...more
Connected medical devices deliver numerous benefits not available before, including improved monitoring of patient welfare and a wealth of vital data. But for all the advantages available through these devices, their...more